IBD-like Lesions in a Secukinumab-treated Patient

Intern Med. 2022 Jul 1;61(13):2077-2078. doi: 10.2169/internalmedicine.8475-21. Epub 2021 Nov 20.
No abstract available

Keywords: inflammatory bowel disease; interleukin-17 inhibitors.

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects
  • Humans
  • Inflammatory Bowel Diseases* / drug therapy
  • Psoriasis*

Substances

  • Antibodies, Monoclonal, Humanized
  • secukinumab